395 related articles for article (PubMed ID: 28800947)
1. [From pathogenesis of giant cell arteritis to new therapeutic targets].
Samson M; Bonnotte B
Rev Med Interne; 2017 Oct; 38(10):670-678. PubMed ID: 28800947
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Giant Cell Arteritis.
Guevara M; Kollipara CS
Curr Rheumatol Rep; 2018 Apr; 20(5):25. PubMed ID: 29611005
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of giant cell arteritis].
Samson M; Greigert H; Ghesquière T; Bonnotte B
Presse Med; 2019 Sep; 48(9):968-979. PubMed ID: 31324351
[TBL] [Abstract][Full Text] [Related]
4. The role of biologics in the treatment of giant cell arteritis.
González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
Expert Opin Biol Ther; 2019 Jan; 19(1):65-72. PubMed ID: 30513026
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis of large vessel vasculitis].
Samson M; Bonnotte B
Rev Med Interne; 2016 Apr; 37(4):264-73. PubMed ID: 26620872
[TBL] [Abstract][Full Text] [Related]
6. Management of large-vessel vasculitis.
Salvarani C; Hatemi G
Curr Opin Rheumatol; 2019 Jan; 31(1):25-31. PubMed ID: 30461542
[TBL] [Abstract][Full Text] [Related]
7. Current and emerging diagnosis tools and therapeutics for giant cell arteritis.
González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
Expert Rev Clin Immunol; 2018 Jul; 14(7):593-605. PubMed ID: 29877748
[TBL] [Abstract][Full Text] [Related]
8. Treatment of giant cell arteritis.
González-Gay MÁ; Pina T; Prieto-Peña D; Calderon-Goercke M; Gualillo O; Castañeda S
Biochem Pharmacol; 2019 Jul; 165():230-239. PubMed ID: 31034796
[TBL] [Abstract][Full Text] [Related]
9. Current Perspectives in Giant Cell Arteritis: Can We Better Connect Pathogenesis and Treatment?
Opriș-Belinski D; Cobilinschi CO; Săulescu I
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541126
[TBL] [Abstract][Full Text] [Related]
10. Ustekinumab for refractory giant cell arteritis: A prospective 52-week trial.
Conway R; O'Neill L; Gallagher P; McCarthy GM; Murphy CC; Veale DJ; Fearon U; Molloy ES
Semin Arthritis Rheum; 2018 Dec; 48(3):523-528. PubMed ID: 29776658
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in our understanding of giant cell arteritis pathogenesis.
Samson M; Corbera-Bellalta M; Audia S; Planas-Rigol E; Martin L; Cid MC; Bonnotte B
Autoimmun Rev; 2017 Aug; 16(8):833-844. PubMed ID: 28564617
[TBL] [Abstract][Full Text] [Related]
12. Giant Cell Arteritis: Beyond Corticosteroids.
Steel L; Khan A; Dasgupta B
Drugs Aging; 2015 Aug; 32(8):591-9. PubMed ID: 26239828
[TBL] [Abstract][Full Text] [Related]
13. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
14. Biological treatments in giant cell arteritis & Takayasu arteritis.
Samson M; Espígol-Frigolé G; Terrades-García N; Prieto-González S; Corbera-Bellalta M; Alba-Rovira R; Hernández-Rodríguez J; Audia S; Bonnotte B; Cid MC
Eur J Intern Med; 2018 Apr; 50():12-19. PubMed ID: 29146018
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients.
Régent A; Redeker S; Deroux A; Kieffer P; Ly KH; Dougados M; Liozon E; Larroche C; Guillevin L; Bouillet L; Espitia O; Costedoat-Chalumeau N; Soubrier M; Brihaye B; Lifermann F; Lefevre G; Puéchal X; Mouthon L; Toussirot E;
J Rheumatol; 2016 Aug; 43(8):1547-52. PubMed ID: 27182063
[TBL] [Abstract][Full Text] [Related]
16. [Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?].
Samson M; Bonnotte B
Rev Med Interne; 2018 Feb; 39(2):75-77. PubMed ID: 29217104
[No Abstract] [Full Text] [Related]
17. Need and value of targeted immunosuppressive therapy in giant cell arteritis.
Sandovici M; van der Geest N; van Sleen Y; Brouwer E
RMD Open; 2022 Feb; 8(1):. PubMed ID: 35149602
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
Hellmich B; Águeda AF; Monti S; Luqmani R
Curr Rheumatol Rep; 2020 Oct; 22(12):84. PubMed ID: 33044642
[TBL] [Abstract][Full Text] [Related]
19. Giant cell arteritis with ocular involvement successfully treated with tocilizumab and very short-course glucocorticoids: A case report.
Khanna RK; Hage R; Lecler A; Sene T; Vignal-Clermont C; Clavel-Refregiers G
J Fr Ophtalmol; 2021 Apr; 44(4):481-484. PubMed ID: 33712335
[TBL] [Abstract][Full Text] [Related]
20. [Management of polymyalgia rheumatica and large vessel vasculitis].
Hellmich B
Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
